---
title: Certara vs PozeSCAF Inc.
slug_a: certara
slug_b: pozescaf-discovery-solutions
site: cro
review_signal_gate: closed
canonical_path: /compare/certara/pozescaf-discovery-solutions
generated_by: BioBM Editorial AI
---

# Certara vs PozeSCAF Inc.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Certara (certara) is listed for cro. Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

Services: 37. Modalities: 20. Indications: 25. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (37).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

PozeSCAF Inc. (pozescaf-discovery-solutions) is listed for cro. Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.

Services: 5. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.